As previously reported, Argus analyst David Coleman downgraded Chemours to Hold after its Q2 earnings miss and lowered FY19 guidance driven by lower volume in its Titanium Technologies business, saying that the near-term on the stock appears to be capped even though longer-term risk-tolerate investors may get a "favorable entry point". The analyst points to the 34% decline in the company's Titanium Technologies segment revenue and a 15% decline in the Chemical Solutions segment sales, with lower mining solutions business volumes impacted by the operational issues at a customer mine.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here